Skip to main content
. 2017 Jan 13;16:6. doi: 10.1186/s12933-016-0490-6

Fig. 1.

Fig. 1

Changes from baseline in the placebo-adjusted mean HR as a function of time for a exenatide 10 µg [20] and b lixisenatide 20 µg QD (Sanofi, data on file). bpm beats per minute, CI confidence interval, HR heart rate, QD once daily. a Reproduced with permission from AstraZeneca